In SSc FBs treated with ETAR siRNA, pSMADs were significantly increased after TGF-β treatment; of note, MAC lacks the ability to inhibit SMAD phosphorylation, such as reported in SSc FBs transfected with scr-siRNA (Fig. 4d). The gene discussed is TGFB1; the disease is systemic sclerosis.